Pliant Therapeutics, Inc.
IPO News: Filed S-1: Pliant Therapeutics Files $86.3mm IPO

Pliant Therapeutics

NASDAQ:  PLRX

Size (mm):  $86.25

Bookrunners:  Citi | Cowen | Piper Sandler

Co-Manager:  Needham

Major Holders:  Third Rock Ventures | Eventide Asset Management | Redmile Group | Cowen Healthcare Investments | Novartis

Description:  Pliant is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis.

Note:  Emerging Growth Company

 

Reference Link:  S-1